Inside Anesthesia: Signals, Surprises, and Strategic Shifts – June 2025
Anesthesia trends, mildly alarming and occasionally useful
This is the first issue of Inside Anesthesia, a recurring monthly scan of what’s actually moving the needle in our world. Not the loudest headlines. Not the LinkedIn spin. Just the real stuff: trends, signals, and strategic shifts that matter.
As someone straddling clinical leadership and corporate strategy, I get to see both the front lines and the financial levers. This series is my way of sharing what I’m seeing, before it shows up on someone else’s PowerPoint.
Let’s take a look around.
📊 Signal 1: Big Market, Small Pieces
The headline
Anesthesia is a 28 billion dollar market, but you wouldn’t know it by looking at who’s holding the bag. About 70 percent of the space is still carved up by hospital-employed groups and regional independents. The largest national players control around 30 percent, give or take some recent M&A and heartburn.
Zoom in
Anesthesia remains one of the most fragmented clinical specialties in healthcare. It’s a massive total addressable market, but it behaves like a local service business with mom-and-pop DNA. Almost every OR is a different village. Every hospital CFO thinks they’re reinventing the wheel. This fragmentation isn’t just inconvenient. It’s strategic white space.
Why it matters
Consolidation plays are coming, but they’re slower and messier than in specialties like radiology or dialysis. Economic headwinds, payer contracts, and staffing complexity keep anesthesia sticky and resistant to roll-up efforts. That said, the scale opportunity is real, especially in ASC-aligned markets where surgical volumes are rising and operators want anesthesia partners who can keep pace.
Watch this space if
You’re building a regional footprint, exploring insourcing, or sitting in a PE office still convinced anesthesia is easy margin. (It’s not.)
🏥 Signal 2: Hospitals Out, ASCs In
The headline
Ascension, one of the largest health systems in the country, is shedding hospitals like they’re underwater assets. Their decision to aggressively divest a significant number of hospitals reflects a larger move away from inpatient care and a growing shift toward outpatient surgery.
Zoom in
At the same time, Ascension is doubling down with a 4 billion dollar acquisition of AmSurg, a major ASC operator. Translation: less brick-and-mortar overhead, more outpatient throughput. ASCs offer what health systems want right now: lower fixed costs, more predictable revenue, and scalable procedures that don’t come with inpatient headaches.
Why it matters
This isn’t just a strategy shift. It’s a signal. As surgical volume moves outpatient, anesthesia groups that aren't ASC-ready are going to struggle. ASCs require faster turns, leaner staffing, and tighter coordination with surgeons. It’s still anesthesia, but with a different rhythm and a different business model underneath.
Watch this space if
You’re overly dependent on inpatient volume, or haven’t yet operationalized your ASC playbook. This trend isn’t reversing.
🎓 Signal 3: The CRNA Pipeline Is Expanding—Slowly
The headline
There are roughly 140 accredited CRNA programs in the U.S., and at least 18 more are in development. That might sound like welcome news in a workforce-constrained environment, but new seats don’t mean instant supply.
Zoom in
Most new programs are regionally focused and small. They face long timelines to full enrollment, with faculty shortages and clinical site limitations acting as bottlenecks. Accreditation hurdles also add friction. Think of this as a slow drip, not a flood.
Why it matters
Staffing is becoming a core strategic function. The anesthesia market can't count on the educational system to solve its workforce issues quickly. Leaders who invest in talent development, mentorship, and clinician retention will outperform those waiting for the cavalry.
Watch this space if
You’re modeling workforce growth off future pipeline assumptions. The math is not mathing. And if you have influence in academia or health system leadership, now is the time to seed long-term solutions. The lack of prioritization here is still surprising.
💸 Signal 4: A Symbolic Win That Doesn’t Touch the Real Pain
The headline
Illinois is set to ban time-based anesthesia payment caps. A bill on the governor’s desk would prevent insurers from limiting reimbursement based solely on how long a case runs. On paper, that looks like a win for providers. In practice, it’s more symbolic than structural.
Zoom in
The legislation is a response to payer proposals (looking at you, Anthem) that tried to shave costs by targeting anesthesia time units. It’s a policy that always felt like a workaround, less about efficiency and more about nudging down reimbursement in a way that wouldn’t trigger a headline. Illinois pushing back is good politics and good optics, but it doesn't address the bigger issues.
Why it matters
The anesthesia reimbursement problem isn't time units. It’s the cumulative effect of opaque rate setting, downward pressure via surprise billing legislation, and structural underpayment of anesthesia services in many markets. Those levers are still fully operational.
Watch this space if
You’re tracking payer behavior, legislative activity, or reimbursement strategy. Celebrate the small wins, but stay focused on the real threats. The erosion of anesthesia value isn’t coming in obvious ways. It’s hiding in policy language, contract clauses, and billing modifiers that no one notices until the check clears light.
Closing Thought
Anesthesia is evolving in multiple directions at once. Market fragmentation, outpatient growth, workforce supply, and payer pressure aren’t isolated problems. They’re overlapping variables in a system that’s overdue for redesign.
Will we see a wave of M&A in anesthesia? Will private equity move to divest large anesthesia platforms? Could a major group break into the public markets with an IPO? Possibly. Meanwhile, outpatient growth continues to outpace inpatient planning, and payers are learning new ways to erode margins with a smile.
None of these trends on their own are existential. But together, they’re nudging the profession toward a new shape. Leaders who pay attention, act early, and adapt fast will set the direction for everyone else.
And remember: if it sounds strategic but solves nothing, it’s probably consulting.
Do you think there’s a way to advocate for legislation around this part “It’s the cumulative effect of opaque rate setting, downward pressure via surprise billing legislation, and structural underpayment of anesthesia services in many markets?” Is it that the bill in Illinois and elsewhere isn’t written well enough to capture points which could resolve the core issues? And what might legislation that was willing to address that look like?
Shortages of clinicians, ASCs historically focus heavy on profits...will this transition lead to lower quality of care?